Evidence map›Paper›PMID 39221402›Full record

ReviewCureus2024

Navigating Prevention: A Systematic Review of Strategies for Alzheimer's Disease in High-Risk and Affected Individuals.

Carlos Luis Guanín Cabrera, Arturo P Jaramillo, Maria P Vallejo, Maria G Cueva, Xavier Grandes, Mario Navarro Grijalva, Over J Hidalgo Guerrero

Abstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Carlos Luis Guanín CabreraGeneral Practice, Universidad Católica de Santiago de Guayaquil, Guayaquil, ECU.
Arturo P JaramilloGeneral Practice, Universidad Estatal de Guayaquil, Machala, ECU.
Maria P VallejoGeneral Practice, Universidad Católica de Santiago de Guayaquil, Guayaquil, ECU.
Maria G CuevaUrology, Universidad Catolica de Santiago de Guayaquil, Guayaquil, ECU.
Xavier GrandesResearch, Universidad Catolica de Santiago de Guayaquil, Guayaquil, ECU.
Mario Navarro GrijalvaInternal Medicine, Universidad Catolica de Santiago de Guayaquil, Guayaquil, ECU.
Over J Hidalgo GuerreroGeneral Practice, Universidad Católica de Santiago de Guayaquil, Guayaquil, ECU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) remains a widespread cause of dementia globally, and its prevalence is increasing due to the aging population. Two key pathologies typically identify this neurodegenerative disease process: the accumulation of amyloid plaques and the formation of neurofibrillary tangles containing hyperphosphorylated tau. Diagnosis relies on the patient's clinical presentation meeting specific criteria, along with the use of fluid and imaging biomarkers. The current treatment focuses on addressing symptoms, with ongoing trials aiming to decrease the production and overall impact of brain pathology. Here, we explore various methods to minimize the risks of AD in patients and individuals at high risk of developing it. To address this, we carefully selected 10 articles that discuss various prevention methods used today to promote brain health, including diets that are believed to have neuroprotective properties. The study findings emphasize the importance of further strengthening the evidence and conducting larger randomized controlled trials to gain a better understanding of the potential benefits for individuals at high risk of developing AD, as well as those already diagnosed with it.

Indexed as

alzheimer’s dementiadementiamind dietneuroprotectorpreventive medicine

Identifiers

PMID39221402
PMCPMC11365738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.